Literature DB >> 1708315

Patients with HIV infection have a reduced proportion of lymphocytes expressing the IL2 receptor p55 chain (TAC, CD25).

H Zola1, L Y Koh, B X Mantzioris, D Rhodes.   

Abstract

Using a high-sensitivity immunofluorescence procedure, a proportion of blood lymphocytes can be shown to express the p55 chain of the IL-2 receptor (CD25, TAC) without in vitro stimulation. In this study, we measured the proportion of peripheral blood lymphocytes expressing CD25 in patients with a diagnosis of HIV infection and compared the results with cells from controls. The mean value for HIV-positive samples was 15%, while controls gave a mean value of 31%. The difference between the groups was highly significant (P less than 0.001, Mann-Whitney U test). When expression of CD25 was examined separately in CD4-positive and CD8-positive T cells and in B cells, there was a wider spread of values in the HIV group compared with controls, but no systematic difference. In the patient group studied (110 samples from 53 patients) there was a weak correlation between CD25 and CD4 expression (correlation coefficient r = 0.21, P less than 0.02), but there were patients with low CD25 and high CD4 as well as patients with high CD25 and low CD4, suggesting that CD25 can vary independently of changes in CD4 lymphocytes. Although the majority of very low values of CD25 (less than 10%) were found in patients with stage IV disease, such low values were also common in Stage II disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1708315     DOI: 10.1016/0090-1229(91)90078-o

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  9 in total

1.  Reproducibility of immunological tests used to assess multiple chemical sensitivity syndrome.

Authors:  Donald R Hoover; Albert Donnay; Clifford S Mitchell; Grace Ziem; Noel R Rose; Daniel E Sabath; Edward J Yurkow; Robert Nakamura; Robert F Vogt; Myron Waxdal; Joseph B Margolick
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

2.  Noncytolytic inhibition of X4 virus by bulk CD8(+) cells from human immunodeficiency virus type 1 (HIV-1)-infected persons and HIV-1-specific cytotoxic T lymphocytes is not mediated by beta-chemokines.

Authors:  R Geiben-Lynn; M Kursar; N V Brown; E L Kerr; A D Luster; B D Walker
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

3.  Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals.

Authors:  Susan Moir; Kisani M Ogwaro; Angela Malaspina; Joshua Vasquez; Eileen T Donoghue; Claire W Hallahan; Shuying Liu; Linda A Ehler; Marie A Planta; Shyamasundaran Kottilil; Tae-Wook Chun; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-01       Impact factor: 11.205

4.  T cell activation and disease severity in HIV infection.

Authors:  M Mahalingam; M Peakman; E T Davies; A Pozniak; T J McManus; D Vergani
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

5.  Relationship between IL-2 receptor expression and proliferative responses in lymphocytes from HIV-1 seropositive homosexual men.

Authors:  R K Chopra; N B Raj; J P Scally; A D Donnenberg; W H Adler; A J Saah; J B Margolick
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

6.  HIV-1 binding to CD4 on CD4+CD25+ regulatory T cells enhances their suppressive function and induces them to home to, and accumulate in, peripheral and mucosal lymphoid tissues: an additional mechanism of immunosuppression.

Authors:  Jiaxiang Ji; Miles W Cloyd
Journal:  Int Immunol       Date:  2009-02-10       Impact factor: 4.823

7.  Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.

Authors:  J H Vingerhoets; G L Vanham; L L Kestens; G G Penne; R L Colebunders; M J Vandenbruaene; J Goeman; P L Gigase; M De Boer; J L Ceuppens
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

Review 8.  Interleukin-2 and human immunodeficiency virus infection: pathogenic mechanisms and potential for immunologic enhancement.

Authors:  A Kinter; A S Fauci
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

9.  Computational analysis of HIV-1 resistance based on gene expression profiles and the virus-host interaction network.

Authors:  Tao Huang; Zhongping Xu; Lei Chen; Yu-Dong Cai; Xiangyin Kong
Journal:  PLoS One       Date:  2011-03-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.